Overview

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

Status:
Recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A phase 3 clinical trial to compare and evaluate efficacy and safety of epaminurad with febuxostat in gout patients.
Phase:
Phase 3
Details
Lead Sponsor:
JW Pharmaceutical
Treatments:
Febuxostat